VANGUARD DA2PI, liofilizzato e solvente per soluzione iniettabile per cani
VANGUARD DA2PI, liofilizzato e solvente per soluzione iniettabile per cani
Not authorised
- Canine distemper virus, strain N-CDV, Live
- Canine parainfluenza virus, strain NL-CPI-5, Live
- Canine adenovirus 2, strain Manhattan, Live
Product identification
Medicine name:
VANGUARD DA2PI, liofilizzato e solvente per soluzione iniettabile per cani
Active substance:
- Canine distemper virus, strain N-CDV, Live
- Canine parainfluenza virus, strain NL-CPI-5, Live
- Canine adenovirus 2, strain Manhattan, Live
Target species:
-
Dog
Route of administration:
-
Subcutaneous use
Product details
Active substance and strength:
-
Canine distemper virus, strain N-CDV, Live3.00/log10 50% cell culture infectious dose1.00Dose
-
Canine parainfluenza virus, strain NL-CPI-5, Live6.00/log10 50% cell culture infectious dose1.00Dose
-
Canine adenovirus 2, strain Manhattan, Live3.20/log10 50% cell culture infectious dose1.00Dose
Pharmaceutical form:
-
Lyophilisate and solvent for solution for injection
Withdrawal period by route of administration:
-
Subcutaneous use
-
Dog
-
Unspecified0day
-
-
Anatomical therapeutic chemical veterinary (ATCvet) codes:
- QI07AD10
Legal status of supply:
-
Veterinary medicinal product subject to veterinary prescription
Authorisation status:
-
Surrendered
Authorised in:
-
Italy
Additional information
Entitlement type:
-
Marketing Authorisation
Legal basis of product authorisation:
-
Full application (Article 12(3) of Directive No 2001/82/EC)
Marketing authorisation holder:
- Zoetis Italia S.r.l
Marketing authorisation date:
Manufacturing sites for batch release:
- Zoetis Belgium
Responsible authority:
- Ministry Of Health
Authorisation number:
This information is not available for this product.
Date of authorisation status change:
To consult adverse reactions on veterinary medicinal products please go to www.adrreports.eu/vet
Documents
Combined File of all Documents
This document does not exist in this language (English). You can find it
in another language below.
Italian (PDF)
Published on: 3/06/2022